Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MRM3 antisense RNA 1 (MRM3-AS1) is classified as a long non-coding RNA (lncRNA) gene located on human chromosome 3[1]. It is transcribed antisense to the MRM3 gene and does not encode a protein product[1]. The biological function of MRM3-AS1 has not been experimentally characterized or linked to specific molecular or clinical phenotypes in currently available biomedical literature or reference databases[1]. Antisense RNAs like MRM3-AS1 can, in general, regulate the expression of neighboring or overlapping genes at various levels (transcription, RNA splicing, stability, translation) and may influence chromatin state or interact with protein complexes important for gene expression[4]. However, there are no data supporting a direct disease role, therapeutic relevance, or interaction with drugs for MRM3-AS1. This makes it distinct from antisense lncRNAs such as MCM3AP-AS1, which have reported roles in cancer biology[2]. Key Notes: - MRM3-AS1 should not be confused with MCM3AP-AS1, which is a well-studied lncRNA implicated in cancer[2]. - There is currently insufficient evidence that MRM3-AS1 is a therapeutic target, a biomarker, or a disease-associated molecule. This entry is primarily a locus/gene annotation and does not describe a conventional therapeutic target such as a receptor, enzyme, transporter, or disease-associated protein. Thus, it is classified as is_target: false and is_incorrect: true for the purposes of standard therapeutic target annotations.
No drugs identified; as an lncRNA, possible mechanisms generally include regulation of mRNA or chromatin states
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MRM3 antisense RNA 1 (MRM3-AS1).